PCAS enters into exclusive negotiations with DIC Corporation following receipt of an offer for the acquisition of its Canadian subsidiary, PCAS Canada Inc.
02 Mai 2023 - 8:25PM
PCAS enters into exclusive negotiations with DIC Corporation
following receipt of an offer for the acquisition of its Canadian
subsidiary, PCAS Canada Inc.
Ecully, May 2nd, 2023
PCAS enters into exclusive negotiations
with DIC Corporation following receipt of an offer
for the acquisition of its Canadian
subsidiary, PCAS Canada Inc.
PCAS (Euronext Paris: PCA),
specialized in the development of processes and production of
complex molecules for Life Sciences and Specialty Chemicals
Markets, announces the receipt of an offer from DIC Corporation, a
Japanese chemical corporate group with a presence in more than 60
countries, for the acquisition of PCAS Canada Inc., the Canadian
subsidiary of PCAS Group. In this context, PCAS and the potential
purchaser have agreed to further entertain exclusive
negotiations.
The offer values PCAS Canada Inc. at an
enterprise value of 88.2 million euros.
PCAS’ potential decision to divest its Canadian
subsidiary and the execution of the related agreements remain in
any case subject to the full completion of the mandatory
information-consultation process of the competent workers’
councils, after authorization of PCAS’ Supervisory Board and
Seqens, its majority shareholder.
Founded in 1989, PCAS Canada Inc. specializes in
the synthesis, development and custom manufacturing of high-quality
materials by managing tight control limits and levels of ppb scale
impurities.
PCAS will provide an update in due time with
regard to any further developments, in accordance with applicable
regulations.
ABOUT PCAS
PCAS specializes in the development and
production of complex molecules for life sciences and innovative
technologies. With about 11% of its net sales earmarked for R&D
and a large international footprint, PCAS is the preferred
industrial partner for market-leading major global groups. Boasting
especially high standards, the company offers a growing range of
proprietary products and solutions in leading-edge segments. PCAS
generated net sales of €226.4 million in 2022 and employs nearly
1200 people in six countries.
To find out more about PCAS: www.pcas.com
PCAS |
NewCap |
Jean-Louis Martin / Eric Moissenot |
Emmanuel Huynh / Louis-Victor Delouvrier
NewCapFinancial communication and investor
relation |
|
|
Tel.: +33 1 69 79 60 00www.pcas.com |
Tel.: +33 1 44 71 98 53pcas@newcap.eu |
|
|
- PCAS - Press release - PCAS Canada Inc - EN - 020523-FINAL
Pcas (LSE:0NF7)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Pcas (LSE:0NF7)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025
Real-Time news about Pcas Sa (London Stock Exchange): 0 recent articles
Plus d'articles sur